Latest Financial Reports News

Page 16 of 52
ChemX Materials remains suspended from ASX trading since December 2024, with no exploration activity reported in Q1 2026. The company secured an unsecured $1.2 million loan facility to support its recapitalisation and operational needs.
Maxwell Dee
Maxwell Dee
21 May 2026
Saluda Medical’s Australian arm has secured ASIC approval to bypass standalone audited financial reports, cutting costs and streamlining compliance.
Ada Torres
Ada Torres
15 May 2026
Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.
Ada Torres
Ada Torres
13 May 2026
Almonty Industries reported a 221% jump in Q1 2026 revenue to CAD 25.4 million, driven by soaring tungsten prices and ramp-up at its Sangdong Mine, while net loss narrowed to CAD 5.3 million amid strong operational cash flow.
Maxwell Dee
Maxwell Dee
12 May 2026
Ainsworth Game Technology has confirmed Ryan Comstock as CEO after six months as acting chief, tying his pay to company performance through incentive plans.
Victor Sage
Victor Sage
11 May 2026
Temas Resources’ 2026 re-assays of 2022 drill samples at La Blache reveal material uplifts in vanadium, gallium, scandium, and chromium grades, strengthening the case for its proprietary Regenerative Chloride Leach technology.
Maxwell Dee
Maxwell Dee
11 May 2026
Navigator Global Investments (ASX: NGI) has kicked off a fully underwritten entitlement offer to raise A$145 million, supporting its US$195 million acquisition of a portfolio of alternative asset manager stakes from Stable Asset Management.
Claire Turing
Claire Turing
11 May 2026
Critical Resources Limited (ASX:CRR) has initiated a pro-rata entitlement offer of Loyalty Options priced at $0.001 each, aiming to raise $319,410 and potentially $2.56 million upon exercise. The offer underscores significant dilution and operational risks amid ongoing exploration and legal challenges.
Maxwell Dee
Maxwell Dee
4 May 2026
NeuRizer Ltd advanced its urea project with Reliance Industries payments and environmental submissions, despite ongoing ASX trading suspension and overdue financial reports.
Maxwell Dee
Maxwell Dee
4 May 2026
The Hydration Pharmaceuticals Company Limited (ASX: HPC) temporarily halted trading to relodge its FY25 Annual Report, revealing a $2.86 million loss driven by US market rationalisation and ongoing cost-cutting.
Ada Torres
Ada Torres
1 May 2026
DUG Technology Ltd recorded a 35% revenue increase in FY26-Q3, surpassing full-year FY25 revenue in just nine months and announcing a strategic move to half-year financial reporting.
Sophie Babbage
Sophie Babbage
1 May 2026
Racura Oncology reported robust progress in Q3 FY2026, including launching a key lung cancer trial and unveiling a novel blood test for cardioprotection, supported by a solid $19.38 million cash position.
Ada Torres
Ada Torres
30 Apr 2026

Browse the archive

Full archive